Education
About Us
Working with TipRanks
Follow Us
Willow Biosciences Inc (TSE:ATLE)
:ATLE
ATLE Stock Chart & Stats
Day’s Range― - ―
52-Week RangeC$0.02 - C$0.53
Previous CloseN/A
VolumeN/A
Average Volume (3M)115.07K
Market Cap
C$67.98M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta1.58
Next Earnings
Aug 18, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.01
Shares Outstanding352,222,660
10 Day Avg. Volume72,396
30 Day Avg. Volume115,066
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.00
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusHold
Number of Analyst Covering0
Options Prices
Currently, No data available
---
Ownership Overview
2.07%
Insiders
―
Mutual Funds
0.12% Other Institutional Investors
97.81% Public Companies and
Individual Investors
ATLE FAQ
What was Willow Biosciences Inc’s price range in the past 12 months?
Willow Biosciences Inc lowest stock price was C$0.02 and its highest was C$0.53 in the past 12 months.
What is Willow Biosciences Inc’s market cap?
Willow Biosciences Inc’s market cap is C$67.98M.
When is Willow Biosciences Inc’s upcoming earnings report date?
Willow Biosciences Inc’s upcoming earnings report date is Aug 18, 2025 which is in 22 days.
How were Willow Biosciences Inc’s earnings last quarter?
Willow Biosciences Inc released its earnings results on May 13, 2025. The company reported -C$0.011 earnings per share for the quarter, missing the consensus estimate of N/A by -C$0.011.
Is Willow Biosciences Inc overvalued?
According to Wall Street analysts Willow Biosciences Inc’s price is currently Overvalued.
Does Willow Biosciences Inc pay dividends?
Willow Biosciences Inc does not currently pay dividends.
What is Willow Biosciences Inc’s EPS estimate?
Willow Biosciences Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Willow Biosciences Inc have?
Willow Biosciences Inc has 352,222,660 shares outstanding.
What happened to Willow Biosciences Inc’s price movement after its last earnings report?
Willow Biosciences Inc reported an EPS of -C$0.011 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -16.667%.
Which hedge fund is a major shareholder of Willow Biosciences Inc?
Currently, no hedge funds are holding shares in TSE:ATLE
Willow Biosciences Inc Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
― (―)
― (―)
Insider Transactions
Bought Shares
Worth C$750.0K over
the Last 3 Months
the Last 3 Months
Technicals
SMA
Negative
20 days / 200 days
Momentum
-60.00%
12-Months-Change
Fundamentals
Return on Equity
-971.43%
Trailing 12-Months
Asset Growth
-49.43%
Trailing 12-Months
Company Description
Willow Biosciences Inc
Willow Biosciences Inc., a biotechnology company, develops, produces, and sells plant derived ingredients for consumer care, food and beverage, and pharmaceutical product industries in Canada. The company also produces cannabidiol, cannabigerol, and varin cannabinoids, such as cannabigerovarin, cannabidivarin, and tetrahydrocannabivarin. Willow Biosciences Inc. was incorporated in 1981 and is headquartered in Calgary, Canada.
Technical Analysis
Terranueva Corp
―
City View Green Holdings
―
Ovation Science
―
New Leaf Ventures
―
Silo Wellness Inc
―